Skip to main content
Clinical Trials/CTRI/2024/06/069317
CTRI/2024/06/069317
Not yet recruiting
Phase 3 4

A Randomized comparative clinical trial to evaluate the efficacy of bharangyadi taila nasya and shadabindu taila nasya with Chitrak haritaki avaleha in kaphaja shiroroga with special reference to chronic maxillary sinusitis

Not provided1 site in 1 country60 target enrollmentStarted: July 15, 2024Last updated:

Overview

Phase
Phase 3 4
Status
Not yet recruiting
Enrollment
60
Locations
1
Primary Endpoint
Symptomatic relief

Overview

Brief Summary

A randomized clinical trial to evaluate the efficacy of bharangyadi taila nasya and shadbindu taila nasya with Chitrakoot haritaki avaleha in kaphaja Shiro roga w.s.r. to chronic maxillary sinusitis

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
16.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Heaviness in head along with dull pain and numbness (guru gauravyukta)
  • Feeling of the head being covered with wet cloth (kaphalipta).
  • Sticky mucus secretion in throat (kaphopadigdhamiti)
  • Headache is less severe than acute sinusitis.
  • Nasal obstruction.
  • Nasal and Post nasal purulent discharge.
  • Facial pain and pressure.
  • Disturbance of smell (hyposmia or anosmia).
  • Patient with chronic maxillary sinusitis were included.
  • Age from 16 years to 70 years.

Exclusion Criteria

  • Patient not willing for the trial were excluded.
  • Patient with acute maxillary sinusitis were excluded.
  • Pregnant women.
  • Lactating women.
  • Patient suffering from Gastritis with sensitive stomach.
  • Patient suffering from diabetes
  • Patient aged below 16 years and above 70 years.
  • Patients suffering from headache of all other causes except Chronic maxillary sinusitis.
  • Patient suffering from cellulitis of cheek and nasal furuncle.
  • Patient with malignancy of sinuses.

Outcomes

Primary Outcomes

Symptomatic relief

Time Frame: 30 days trial

Prevention of recurrence

Time Frame: 30 days trial

Secondary Outcomes

  • Relief in complications(Reduced quality of life)

Investigators

Sponsor
Not provided
Responsible Party
Principal Investigator
Principal Investigator

Shital Chaudhari

National Institute of Ayurveda, Jaipur.

Study Sites (1)

Loading locations...

Similar Trials